iRhythm Holdings (IRTC) Cash & Equivalents Growth (1y) (2016 - 2026)
iRhythm Holdings (IRTC) Cash & Equivalents Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -26.57% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 42.78% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | -12.13% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 0.94% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | -11.19% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | -4.66% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -44.03% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 19.49% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 72.43% |
| 10 | iRhythm Holdings | 4.18 Bn | 3.59 Bn | 163.21 Mn | -20.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -20.20% |
| Mar 31, 2026 | -36.01% |
| Dec 31, 2025 | -43.75% |
| Sep 30, 2025 | -68.73% |
| Jun 30, 2025 | -61.05% |
| Mar 31, 2025 | -27.89% |
| Dec 31, 2024 | 1,059.97% |
| Sep 30, 2024 | 994.26% |
| Jun 30, 2024 | 794.07% |
| Mar 31, 2024 | 885.57% |
| Dec 31, 2023 | -54.11% |
| Sep 30, 2023 | -33.34% |
| Jun 30, 2023 | -39.18% |
| Mar 31, 2023 | 23.99% |
| Dec 31, 2022 | -28.42% |
| Sep 30, 2022 | -46.21% |
| Jun 30, 2022 | -3.21% |
| Mar 31, 2022 | -69.00% |
| Dec 31, 2021 | 84.10% |
| Sep 30, 2021 | 38.88% |